Electromyographic (EMG) Biofeedback Training in Zone I-III Flexor Tendon Injuries
NCT ID: NCT04237415
Last Updated: 2020-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2016-10-10
2019-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Materials and Methods: Cases who underwent surgery for flexor tendon injuries in zone I-III were included in this prospective randomized controlled trial. Cases were randomly divided into two groups of 11 cases each by block randomization. In the first group, EMG biofeedback training was applied in addition to the early passive motion method (modified Duran protocol), while the second group was followed only by early passive motion method. The treatment program was performed by the same physiotherapist three times a week, for 12 weeks. At the postoperative 5th, 12th and 24th weeks, joint range of motion (ROM) and EMA were evaluated, and the Michigan Hand Outcome Questionnaire (MHQ) was administered to the patients. The grip strength at 12th and 24th weeks were also assessed. The Mann-Whitney U Test was used to compare the two groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Finger Muscle Reaction After Electrical Stimuli to the Human Finger Pulley System; a Pilot Study
NCT01456871
Acute Effects of Interferential Current on Edema, Pain and Muscle Strength in Patients With Distal Radius Fracture
NCT03438864
EMG Activation of Gluteal Musculature During Exercises With and Without Resistance
NCT01841216
Application of Different Techniques of Elastic Bandage
NCT03103048
Effect of Scapular Stabilization Exercises and ESWT in Patients With Lateral Epicondylitis
NCT07238413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EMG biofeedback group
EMG biofeedback training
control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EMG biofeedback training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No history of neurological, orthopedic, rheumatologic disease or trauma in the related extremity,
* No history of neuropathy due to a metabolic disease (diabetes, etc.),
* Incision of at least one of the FDS or FDP tendons,
* At least one of the FDS or FDP tendons repaired within 2 weeks after the injury,
* No communication problems.
Exclusion Criteria
* Pregnancy,
* Thumb flexor tendon cuts,
* Digital nerve injury,
* Accompanying fracture, joint capsule injury or skin loss,
* Crush injury,
* Patients with pacemakers,
* Patients with cardiac arrhythmias,
* Epilepsy.
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pamukkale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UMUT ERASLAN
Research Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ali Kitis, PhD
Role: STUDY_DIRECTOR
Pamukkale University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
60116787-020/50298
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.